CN112655971A - Collagen peptide composition for relieving eye dryness and fatigue and preparation method thereof - Google Patents

Collagen peptide composition for relieving eye dryness and fatigue and preparation method thereof Download PDF

Info

Publication number
CN112655971A
CN112655971A CN202011519733.8A CN202011519733A CN112655971A CN 112655971 A CN112655971 A CN 112655971A CN 202011519733 A CN202011519733 A CN 202011519733A CN 112655971 A CN112655971 A CN 112655971A
Authority
CN
China
Prior art keywords
parts
vitamin
collagen peptide
fatigue
peptide composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011519733.8A
Other languages
Chinese (zh)
Inventor
于利平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kangluoxin Guangdong Biotechnology Co ltd
Original Assignee
Kangluoxin Guangdong Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kangluoxin Guangdong Biotechnology Co ltd filed Critical Kangluoxin Guangdong Biotechnology Co ltd
Priority to CN202011519733.8A priority Critical patent/CN112655971A/en
Publication of CN112655971A publication Critical patent/CN112655971A/en
Pending legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention discloses a collagen peptide composition for relieving eye dry fatigue and a preparation method thereof, and relates to the technical field of collagen peptide compositions, wherein the collagen peptide composition for relieving eye dry fatigue comprises the following raw material components in parts by weight: 5000 portions of collagen peptide 4000-containing-; the zinc agent is one or more of zinc gluconate and zinc lactate; the iron agent is one or more of ferrous gluconate, ferric ammonium citrate, ferric citrate and ferric lactate; the compound vitamin is selected from vitamin A, vitamin D, vitamin C, vitamin B and vitamin E. The collagen peptide composition provided by the invention can solve the problems of dry eyes and eye fatigue, can be used for a long time, and has the effective rate of over 93%.

Description

Collagen peptide composition for relieving eye dryness and fatigue and preparation method thereof
Technical Field
The invention relates to the technical field of collagen peptide compositions, in particular to a collagen peptide composition for relieving eye dryness and fatigue and a preparation method thereof.
Background
In the information-oriented era, as electronic products occupy more and more time of modern people and watch electronic screens for a long time, eye problems of dry eyes and eye fatigue of people are often caused, one of the eye injury factors is blue light emitted by the electronic display screen, the wavelength of the blue light is 400-500nm, the blue light is the most harmful part in visible light, and the blue light can directly penetrate through the crystalline lens of the eyes to reach the retina and cause injury to the retina and a macular area. In addition, excessive eye use can lead to insufficient liver blood supply and thus insufficient nutrient supply to the eyes, which can lead to eye problems that are difficult to recover from.
The existing products for improving the dryness and fatigue of the eyes are eye drops and an eye massager. Wherein, the eye drops contain western medicine components such as antibiotics and the like, and can not be used for a long time. The eye massager can only massage the outside and cannot provide the nutrition required by the eyes. Therefore, the existing product can not fundamentally solve the eye problems of dry eyes and eye fatigue.
Disclosure of Invention
Aiming at the defects in the prior art, the invention provides a collagen peptide composition for relieving eye dryness and fatigue and a preparation method thereof.
The collagen peptide composition for relieving eye dryness and fatigue comprises the following raw material components in parts by weight: 5000 portions of collagen peptide 4000-containing-; the zinc agent is one or more of zinc gluconate and zinc lactate; the iron agent is one or more of ferrous gluconate, ferric ammonium citrate, ferric citrate and ferric lactate; the compound vitamin is selected from vitamin A, vitamin D, vitamin C, vitamin B and vitamin E.
Preferably, the collagen peptide composition for relieving eye dryness and fatigue further comprises the following raw material components in parts by weight: 20-35 parts of orange peel extract, 8-18 parts of hippeastrum extract, 16-20 parts of DHA fish oil powder, 3-7 parts of taurine and 1-3 parts of beta-carotene.
Further preferably, the zinc agent is zinc gluconate and zinc lactate, and the weight part ratio of the zinc gluconate to the zinc lactate is 1.5: 1; the iron agent is ferrous gluconate, ferric ammonium citrate, ferric citrate and ferric lactate, and the weight part ratio of the ferrous gluconate to the ferric ammonium citrate to the ferric lactate is 1: 3: 3: 1; the compound vitamins comprise vitamin A, vitamin D, vitamin C, vitamin B and vitamin E, and the weight part ratio of the vitamin A to the vitamin D to the vitamin C to the vitamin B to the vitamin E is 3:1:1: 1.
Still further preferably, the collagen peptide composition for relieving eye dryness and fatigue comprises the following raw material components in parts by weight: 4000 parts of collagen peptide, 2 parts of lutein ester, 1 part of zeaxanthin, 2 parts of zinc agent, 4 parts of iron agent, 500 parts of compound vitamin, 20 parts of orange peel extract, 8 parts of hippeastrum extract, 16 parts of DHA fish oil powder, 3 parts of taurine and 1 part of beta-carotene.
Still further preferably, the collagen peptide composition for relieving eye dryness and fatigue comprises the following raw material components in parts by weight: 4500 parts of collagen peptide, 6 parts of lutein ester, 1.5 parts of zeaxanthin, 4 parts of zinc agent, 6 parts of iron agent, 750 parts of compound vitamin, 27 parts of orange peel extract, 13 parts of rubus corchorifolius extract, 18 parts of DHA fish oil powder, 5 parts of taurine and 2 parts of beta-carotene.
Still further preferably, the collagen peptide composition for relieving eye dryness and fatigue comprises the following raw material components in parts by weight: 5000 parts of collagen peptide, 10 parts of lutein ester, 2 parts of zeaxanthin, 6 parts of zinc agent, 8 parts of iron agent, 1000 parts of vitamin complex, 35 parts of orange peel extract, 18 parts of Maji berry extract, 20 parts of DHA fish oil powder, 7 parts of taurine and 3 parts of beta-carotene.
The preparation method of the collagen peptide composition for relieving eye dryness and fatigue comprises the following steps: the raw materials are crushed, sieved and mixed uniformly to prepare the collagen peptide composition for relieving eye dryness and fatigue.
Preferably, the sieving is 100-120 mesh sieving.
The invention has the following functions of the raw material components:
collagen peptide: the collagen protein is the most abundant protein in human body and is also the main component of the cornea, and the collagen protein can improve the transmittance of the vitreous body and the cornea in the eyeball, so that the vitreous body and the cornea can keep transparent, and the visual field can be clearer. After the collagen is treated by modern enzyme preparations, micromolecular collagen peptide can be obtained, and the absorption rate and the utilization rate of the collagen peptide are higher than those of the collagen.
Lutein: lutein is a fat-soluble vitamin with an absorption spectrum containing near-blue-violet light that helps the retina of the eye to protect against ultraviolet light. Lutein is an important antioxidant for the eye to play a role. The lutein supplement is beneficial to maintaining the visual endurance, improving the visual response time and reducing the visual injury. Mammals such as humans cannot synthesize lutein by themselves, and foreign foods are the only source of lutein intake.
Zeaxanthin: zeaxanthin is mainly distributed in tissues and organs such as eyes, liver, pancreas, kidney, spleen, ovary and the like, and plays an important role in health. In the eye, zeaxanthin is mainly concentrated in the center of the macular region of the retina. Zeaxanthin cannot be synthesized by humans and animals themselves and must be obtained from food or supplements.
Vitamin complex: vitamins are some small amount of organic compounds necessary for human and animal nutrition and growth, and play an important role in metabolism, growth, development and health of organisms. Among them, vitamin a is also called anti-xerophthalmia vitamin.
Zinc agent: zinc is one of essential trace elements for human body, plays an extremely important role in the growth and development process of human body, and can promote the recovery of human body and improve the immunity of human body by supplementing zinc.
Iron agent: iron is a constituent of hemoglobin, which is involved in the transport and storage of oxygen. Iron supplement can promote hemoglobin synthesis, and is beneficial to eye nutrition supply.
Kumquat peel extract: the kumquat peel is rich in nutrition, has a detoxifying function on the liver, and has the effects of protecting eyes and protecting an immune system.
Extract of rubus corchorifolius: is rich in antioxidant, and can prevent damage of eye cells caused by light induction.
DHA fish oil powder: can improve vision and maintain retina health.
Taurine: taurine can maintain the stable function of retina and keep the vision sharp.
Beta-carotene: preventing dry eyes, absence of spirit, visual deterioration, nyctalopia, cataract, etc.
The invention has the beneficial effects that:
(1) the collagen peptide composition for relieving eye dryness and fatigue provided by the invention adopts raw material components such as collagen peptide and the like, so that sufficient nutrient substances can be provided for eyes, the problem of eye nutrient deficiency caused by excessive eye use is fundamentally solved, and the problems of eye dryness and eye fatigue are further solved. The raw material components are safe and healthy, western medicines are not adopted, the eye drop can be used for a long time, no side effect is caused, and the drug resistance phenomenon caused by long-term use of the eye drop is avoided. The lutein and zeaxanthin in the raw material components are absorbed by human body and accumulated in retina and macula lutea area, which can help eyes filter harmful blue light.
(2) The preparation method provided by the invention is simple to operate, the technology is stable, the raw materials are easy to obtain, the effective rate of the prepared collagen peptide composition for relieving eye dryness and fatigue reaches more than 93%, and the collagen peptide composition has a great commercial value.
Detailed Description
Hereinafter, embodiments of the present invention will be described in detail. The following examples are only for illustrating the technical solutions of the present invention more clearly, and therefore are only examples, and the protection scope of the present invention is not limited thereby.
It is to be noted that, unless otherwise specified, technical or scientific terms used herein shall have the ordinary meaning as understood by those skilled in the art to which the invention pertains.
Example 1
The collagen peptide composition for relieving eye dry fatigue comprises the following raw material components in parts by weight:
4000 parts of collagen peptide, 2 parts of lutein ester, 1 part of zeaxanthin, 2 parts of zinc agent, 4 parts of iron agent, 500 parts of compound vitamin, 20 parts of orange peel extract, 8 parts of hippeastrum extract, 16 parts of DHA fish oil powder, 3 parts of taurine and 1 part of beta-carotene.
The zinc agent is zinc gluconate and zinc lactate, and the weight part ratio of the zinc gluconate to the zinc lactate is 1.5: 1;
the iron agent is ferrous gluconate, ferric ammonium citrate, ferric citrate and ferric lactate, and the weight part ratio of the ferrous gluconate to the ferric ammonium citrate to the ferric lactate is 1: 3: 3: 1;
the compound vitamins comprise vitamin A, vitamin D, vitamin C, vitamin B and vitamin E, and the weight part ratio of the vitamin A to the vitamin D to the vitamin C to the vitamin B to the vitamin E is 3:1:1: 1.
The preparation method of the collagen peptide composition for relieving eye dryness and fatigue comprises the following steps: the raw materials are crushed, sieved and mixed uniformly to prepare the collagen peptide composition for relieving eye dryness and fatigue.
The sieving is 120-mesh sieving.
Example 2
The collagen peptide composition for relieving eye dry fatigue comprises the following raw material components in parts by weight:
4500 parts of collagen peptide, 6 parts of lutein ester, 1.5 parts of zeaxanthin, 4 parts of zinc agent, 6 parts of iron agent, 750 parts of compound vitamin, 27 parts of orange peel extract, 13 parts of rubus corchorifolius extract, 18 parts of DHA fish oil powder, 5 parts of taurine and 2 parts of beta-carotene.
The zinc agent is zinc gluconate and zinc lactate, and the weight part ratio of the zinc gluconate to the zinc lactate is 1.5: 1;
the iron agent is ferrous gluconate, ferric ammonium citrate, ferric citrate and ferric lactate, and the weight part ratio of the ferrous gluconate to the ferric ammonium citrate to the ferric lactate is 1: 3: 3: 1;
the compound vitamins comprise vitamin A, vitamin D, vitamin C, vitamin B and vitamin E, and the weight part ratio of the vitamin A to the vitamin D to the vitamin C to the vitamin B to the vitamin E is 3:1:1: 1.
The preparation method of the collagen peptide composition for relieving eye dryness and fatigue comprises the following steps: the raw materials are crushed, sieved and mixed uniformly to prepare the collagen peptide composition for relieving eye dryness and fatigue.
The sieving is 120-mesh sieving.
Example 3
The collagen peptide composition for relieving eye dry fatigue comprises the following raw material components in parts by weight:
5000 parts of collagen peptide, 10 parts of lutein ester, 2 parts of zeaxanthin, 6 parts of zinc agent, 8 parts of iron agent, 1000 parts of vitamin complex, 35 parts of orange peel extract, 18 parts of Maji berry extract, 20 parts of DHA fish oil powder, 7 parts of taurine and 3 parts of beta-carotene.
The zinc agent is zinc gluconate and zinc lactate, and the weight part ratio of the zinc gluconate to the zinc lactate is 1.5: 1;
the iron agent is ferrous gluconate, ferric ammonium citrate, ferric citrate and ferric lactate, and the weight part ratio of the ferrous gluconate to the ferric ammonium citrate to the ferric lactate is 1: 3: 3: 1;
the compound vitamins comprise vitamin A, vitamin D, vitamin C, vitamin B and vitamin E, and the weight part ratio of the vitamin A to the vitamin D to the vitamin C to the vitamin B to the vitamin E is 3:1:1: 1.
The preparation method of the collagen peptide composition for relieving eye dryness and fatigue comprises the following steps: the raw materials are crushed, sieved and mixed uniformly to prepare the collagen peptide composition for relieving eye dryness and fatigue.
The sieving is 120-mesh sieving.
Test examples
The testing personnel: recruiting 258 local testers with unlimited gender and age, wherein 132 patients with dry eyes symptoms; people 126 with symptoms of eye fatigue.
The test method comprises the following steps: the two patients with symptoms are divided into 3 groups respectively, and take the collagen peptide composition for relieving eye dryness and fatigue prepared in the embodiment 1-3 of the invention.
The taking method comprises the following steps: the traditional Chinese medicine composition is taken twice a day, 5g each time in the morning and at night, for 90 days continuously, and the effective rate is tested, and the results are shown in table 1.
TABLE 1
Figure BDA0002848551920000061
Figure BDA0002848551920000071
As can be seen from table 1, the collagen peptide composition for relieving eye dryness and fatigue prepared by the preparation method provided by the invention can effectively solve the problems of eye dryness and eye fatigue, and the effective rates are respectively higher than 93% and 97%.
Finally, it should be noted that: the above embodiments are only used to illustrate the technical solution of the present invention, and not to limit the same; while the invention has been described in detail and with reference to the foregoing embodiments, it will be understood by those skilled in the art that: the technical solutions described in the foregoing embodiments may still be modified, or some or all of the technical features may be equivalently replaced; such modifications and substitutions do not depart from the spirit and scope of the present invention, and they should be construed as being included in the following claims and description.

Claims (8)

1. A collagen peptide composition for relieving eye dryness and fatigue, which is characterized in that: the collagen peptide composition for relieving eye dryness and fatigue comprises the following raw material components in parts by weight: 5000 portions of collagen peptide 4000-containing-; the zinc agent is one or more of zinc gluconate and zinc lactate; the iron agent is one or more of ferrous gluconate, ferric ammonium citrate, ferric citrate and ferric lactate; the compound vitamin is selected from vitamin A, vitamin D, vitamin C, vitamin B and vitamin E.
2. The collagen peptide composition for relieving eye dry fatigue according to claim 1, wherein: the collagen peptide composition for relieving eye dryness and fatigue further comprises the following raw material components in parts by weight: 20-35 parts of orange peel extract, 8-18 parts of hippeastrum extract, 16-20 parts of DHA fish oil powder, 3-7 parts of taurine and 1-3 parts of beta-carotene.
3. The collagen peptide composition for relieving eye dry fatigue according to claim 2, wherein: the zinc agent is zinc gluconate and zinc lactate, and the weight part ratio of the zinc gluconate to the zinc lactate is 1.5: 1; the iron agent is ferrous gluconate, ferric ammonium citrate, ferric citrate and ferric lactate, and the weight part ratio of the ferrous gluconate to the ferric ammonium citrate to the ferric lactate is 1: 3: 3: 1; the compound vitamins comprise vitamin A, vitamin D, vitamin C, vitamin B and vitamin E, and the weight part ratio of the vitamin A to the vitamin D to the vitamin C to the vitamin B to the vitamin E is 3:1:1: 1.
4. The collagen peptide composition for relieving eye dry fatigue according to claim 3, wherein: the collagen peptide composition for relieving eye dryness and fatigue comprises the following raw material components in parts by weight: 4000 parts of collagen peptide, 2 parts of lutein ester, 1 part of zeaxanthin, 2 parts of zinc agent, 4 parts of iron agent, 500 parts of compound vitamin, 20 parts of orange peel extract, 8 parts of hippeastrum extract, 16 parts of DHA fish oil powder, 3 parts of taurine and 1 part of beta-carotene.
5. The collagen peptide composition for relieving eye dry fatigue according to claim 3, wherein: the collagen peptide composition for relieving eye dryness and fatigue comprises the following raw material components in parts by weight: 4500 parts of collagen peptide, 6 parts of lutein ester, 1.5 parts of zeaxanthin, 4 parts of zinc agent, 6 parts of iron agent, 750 parts of compound vitamin, 27 parts of orange peel extract, 13 parts of rubus corchorifolius extract, 18 parts of DHA fish oil powder, 5 parts of taurine and 2 parts of beta-carotene.
6. The collagen peptide composition for relieving eye dry fatigue according to claim 3, wherein: the collagen peptide composition for relieving eye dryness and fatigue comprises the following raw material components in parts by weight: 5000 parts of collagen peptide, 10 parts of lutein ester, 2 parts of zeaxanthin, 6 parts of zinc agent, 8 parts of iron agent, 1000 parts of vitamin complex, 35 parts of orange peel extract, 18 parts of Maji berry extract, 20 parts of DHA fish oil powder, 7 parts of taurine and 3 parts of beta-carotene.
7. A method of preparing a collagen peptide composition for relieving dry eye fatigue as claimed in any one of claims 1 to 6, wherein: the preparation method comprises the following steps: the raw materials are crushed, sieved and mixed uniformly to prepare the collagen peptide composition for relieving eye dryness and fatigue.
8. The method for preparing a collagen peptide composition for relieving eye dry fatigue as claimed in claim 7, wherein: the sieving is 100-120 mesh sieving.
CN202011519733.8A 2020-12-21 2020-12-21 Collagen peptide composition for relieving eye dryness and fatigue and preparation method thereof Pending CN112655971A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011519733.8A CN112655971A (en) 2020-12-21 2020-12-21 Collagen peptide composition for relieving eye dryness and fatigue and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011519733.8A CN112655971A (en) 2020-12-21 2020-12-21 Collagen peptide composition for relieving eye dryness and fatigue and preparation method thereof

Publications (1)

Publication Number Publication Date
CN112655971A true CN112655971A (en) 2021-04-16

Family

ID=75406895

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011519733.8A Pending CN112655971A (en) 2020-12-21 2020-12-21 Collagen peptide composition for relieving eye dryness and fatigue and preparation method thereof

Country Status (1)

Country Link
CN (1) CN112655971A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114946985A (en) * 2021-12-30 2022-08-30 潘哒鲁鲁(深圳)生物科技有限公司 Functional candy with high-efficiency asthenopia relieving effect and industrial production method
CN115105581A (en) * 2022-08-31 2022-09-27 北京世纪伟信医药科技有限公司 Collagen peptide-containing eye drops for relieving and production method thereof
CN116076722A (en) * 2023-02-17 2023-05-09 华北制药河北华维健康产业有限公司 Lutein beta carotene chewable tablet and preparation method thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009159929A (en) * 2007-12-13 2009-07-23 Fujifilm Corp Oily composition
CN104351808A (en) * 2014-11-17 2015-02-18 威海桦众节能设备有限公司 Health food capable of protecting eyes and relieving visual fatigue
CN105412354A (en) * 2015-12-01 2016-03-23 苟春虎 Eye protecting lollipop containing lycium ruthenicum Murr.
CN109619566A (en) * 2019-01-22 2019-04-16 广州硕维食品技术有限公司 A kind of nutraceutical for alleviating asthenopia
CN109731027A (en) * 2019-03-08 2019-05-10 储殷 Facilitate the composition and preparation method thereof of alleviation visual fatigue and xerophthalmia series symptom
CN110051004A (en) * 2019-04-10 2019-07-26 张秀惠 A kind of composition and preparation method thereof with eye-protecting function
CN111449138A (en) * 2020-05-07 2020-07-28 广州市美素力营养品有限公司 Eyesight-protecting children formula milk powder and preparation method thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009159929A (en) * 2007-12-13 2009-07-23 Fujifilm Corp Oily composition
CN104351808A (en) * 2014-11-17 2015-02-18 威海桦众节能设备有限公司 Health food capable of protecting eyes and relieving visual fatigue
CN105412354A (en) * 2015-12-01 2016-03-23 苟春虎 Eye protecting lollipop containing lycium ruthenicum Murr.
CN109619566A (en) * 2019-01-22 2019-04-16 广州硕维食品技术有限公司 A kind of nutraceutical for alleviating asthenopia
CN109731027A (en) * 2019-03-08 2019-05-10 储殷 Facilitate the composition and preparation method thereof of alleviation visual fatigue and xerophthalmia series symptom
CN110051004A (en) * 2019-04-10 2019-07-26 张秀惠 A kind of composition and preparation method thereof with eye-protecting function
CN111449138A (en) * 2020-05-07 2020-07-28 广州市美素力营养品有限公司 Eyesight-protecting children formula milk powder and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
宁俊恩: "《从眼开始谈养生》", 30 September 2014, 河北科学技术出版社 *
汉竹: "《吃对蔬果不生病》", 31 January 2011, 中国轻工业出版社 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114946985A (en) * 2021-12-30 2022-08-30 潘哒鲁鲁(深圳)生物科技有限公司 Functional candy with high-efficiency asthenopia relieving effect and industrial production method
CN115105581A (en) * 2022-08-31 2022-09-27 北京世纪伟信医药科技有限公司 Collagen peptide-containing eye drops for relieving and production method thereof
CN116076722A (en) * 2023-02-17 2023-05-09 华北制药河北华维健康产业有限公司 Lutein beta carotene chewable tablet and preparation method thereof

Similar Documents

Publication Publication Date Title
CN112655971A (en) Collagen peptide composition for relieving eye dryness and fatigue and preparation method thereof
Meléndez-Martínez et al. Carotenoids: Considerations for their use in functional foods, nutraceuticals, nutricosmetics, supplements, botanicals, and novel foods in the context of sustainability, circular economy, and climate change
US7282225B1 (en) Composition and methods for improving retinal health
US7887847B2 (en) Nutritional supplement for treatment of ocular diseases
EP1516542B1 (en) Nutritional supplement to treat macular degeneration
US20100074969A1 (en) Method of controlling blood sugar levels, insulin levels, cholesterol levels, body fat levels, and body weight by administering a nutrient fiber matrix
US20080268095A1 (en) Dietary Supplement for the Compensation of Nutritional Deficiency
CN103431390B (en) Lycium ruthenicum eyesight improving preparation
CN104083468A (en) Medicine for treating male oligospermia and asthenozoospermia and improving sperm quality
CN102742656B (en) Milky tea relieving asthenopia and preparation method thereof
CN104839688A (en) Eye care preparation and preparation method thereof
CN109645201A (en) Composition containing lutein and lutein ester, lutein pressed candy and preparation method and application
CN104147081A (en) Blueberry lutein soft capsule for improving eyesight and manufacturing method thereof
CN109663122A (en) It is a kind of to provide nutrition, improvement eyesight, the composition grain electuary for preventing eye disease and preparation method thereof for macula retinae area
US20160151437A1 (en) Nutritional supplements for improved vision and methods of treating the same
CN103300373A (en) Lutein and procyanidine composite soft capsule and preparation method thereof
CN105795474A (en) Nutritious visual cell, composition capable of improving regulating ability and resisting blue light damage and preparation method of composition
CN108041609B (en) Food composition with functions of relieving visual fatigue and preventing myopia and preparation method thereof
CN106617055A (en) Eye-protecting healthcare food for relieving degenerative eye diseases and preparation method thereof
CN111528421A (en) Eye-protecting product containing plant exosomes and preparation method thereof
CN103070877A (en) Vision care drug
US20040254095A1 (en) Supplement for treating musculoskeletal disorders
CN109619189A (en) A kind of black fruit Sorbus alnifloria eye protecting milk tablet of sea-buckthorn and preparation method thereof
CN110226751A (en) A kind of composition with eye protection effect
CN111449138A (en) Eyesight-protecting children formula milk powder and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20210416